Aggressive cancer cells malignant b cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

B-Lymphocytes Cell Line, Tumor Tumor Cells, Cultured B-Lymphocyte Subsets Cells, Cultured T-Lymphocytes Cell Line HCT116 Cells MCF-7 Cells HT29 Cells Germinal Center Spleen Neoplastic Stem Cells Breast Precursor Cells, B-Lymphoid Epithelial Cells Lymph Nodes Prostate HeLa Cells Clone Cells Cell Nucleus

Organisms7

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Mice, Transgenic Mice, Knockout Adenoviridae

Diseases46

Lymphoma, B-Cell Leukemia, B-Cell Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Hairy Cell Waldenstrom Macroglobulinemia Neoplasms Neoplasm Invasiveness Burkitt Lymphoma Breast Neoplasms Rhabdoid Tumor Prostatic Neoplasms Neoplasm Metastasis Lymphoma, Non-Hodgkin Leukemia, Lymphoid Lymphoma Pancreatic Neoplasms Multiple Myeloma Mesothelioma Cell Transformation, Neoplastic Lymphoma, Follicular Colonic Neoplasms Carcinoma, Squamous Cell Disease Progression Ovarian Neoplasms Lymphoma, Large B-Cell, Diffuse Lung Neoplasms Stomach Neoplasms Carcinoma Colorectal Neoplasms Adenocarcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Neoplasms, Hormone-Dependent Genetic Predisposition to Disease Endometrial Neoplasms Neovascularization, Pathologic Liver Neoplasms Bone Neoplasms Carcinoma, Small Cell Esophageal Neoplasms Mammary Neoplasms, Experimental Neoplasm Recurrence, Local Neoplasms, Glandular and Epithelial Rectal Neoplasms Mouth Neoplasms

Chemicals and Drugs85

Antigens, CD19 Sialic Acid Binding Ig-like Lectin 2 Antigens, CD20 Antibodies, Monoclonal B-Cell Activating Factor Antibodies, Bispecific Antineoplastic Agents Antibodies, Monoclonal, Murine-Derived Receptors, Antigen, B-Cell Antigens, CD Proto-Oncogene Proteins c-bcl-2 Antigens, Neoplasm RNA, Messenger Immunoglobulin Heavy Chains Immunoglobulin M Tumor Markers, Biological Neoplasm Proteins Transcription Factors RNA, Small Interfering B-Cell Activation Factor Receptor Antigens, CD5 Antigens, Differentiation, B-Lymphocyte CD40 Ligand Immunoglobulin Variable Region Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Receptors, Estrogen Receptor, erbB-2 DNA, Neoplasm Immunoglobulin D Proto-Oncogene Proteins c-akt DNA-Binding Proteins Cancer Vaccines Proto-Oncogene Proteins Tamoxifen Cisplatin Receptor, Epidermal Growth Factor RNA, Neoplasm MicroRNAs Receptors, Androgen Tumor Suppressor Proteins Anticarcinogenic Agents Paclitaxel Androgens Apoptosis Regulatory Proteins Enzyme Inhibitors Estrogen Receptor alpha Nuclear Proteins Immunoglobulin G Protein-Serine-Threonine Kinases Membrane Proteins Caspases DNA Primers Antigens, CD40 Caspase 3 NF-kappa B Prostate-Specific Antigen Protein Kinase Inhibitors Immunoglobulins Phosphatidylinositol 3-Kinases Fluorouracil Inhibitor of Apoptosis Proteins Membrane Glycoproteins Antimetabolites, Antineoplastic Receptors, Progesterone Antibiotics, Antineoplastic Estrogens Antineoplastic Agents, Hormonal beta Catenin Cell Cycle Proteins Cadherins Cyclin-Dependent Kinase Inhibitor p21 Estradiol Intracellular Signaling Peptides and Proteins Cyclin D1 Plant Extracts Estrogen Antagonists Adaptor Proteins, Signal Transducing Proto-Oncogene Proteins c-myc Poly(ADP-ribose) Polymerases bcl-2-Associated X Protein Hydroxamic Acids TNF-Related Apoptosis-Inducing Ligand Quinazolines Carrier Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment43

Flow Cytometry Lymphocyte Activation Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Prognosis Immunohistochemistry Early Detection of Cancer Blotting, Western Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Transfection Neoplasm Transplantation Transplantation, Heterologous Gene Knockdown Techniques Oligonucleotide Array Sequence Analysis Antineoplastic Combined Chemotherapy Protocols Tumor Burden Survival Analysis Survival Rate Models, Biological Inhibitory Concentration 50 Molecular Targeted Therapy Neoplasm Staging Immunoblotting Tumor Stem Cell Assay Follow-Up Studies Real-Time Polymerase Chain Reaction Retrospective Studies Risk Immunoenzyme Techniques Combined Modality Therapy Genetic Therapy Enzyme-Linked Immunosorbent Assay Mammary Neoplasms, Experimental Registries Prospective Studies Disease-Free Survival Drug Delivery Systems Polymerase Chain Reaction Fluorescent Antibody Technique Cell Separation Immunoprecipitation Sensitivity and Specificity

Phenomena and Processes53

Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Cell Survival Signal Transduction Cell Movement Lymphocyte Activation Antibody-Dependent Cell Cytotoxicity Antibody Specificity Drug Resistance, Neoplasm Cell Division Down-Regulation Cell Cycle Transfection Up-Regulation Immunoglobulin Variable Region RNA Interference Cell Growth Processes Promoter Regions, Genetic Phosphorylation Mutation Cell Differentiation Base Sequence Dose-Response Relationship, Drug Gene Silencing Drug Synergism Gene Expression Transcription, Genetic Enzyme Activation Phenotype Cell Adhesion Inhibitory Concentration 50 Genetic Predisposition to Disease Lymphocyte Cooperation Cell Death Protein Binding Epithelial-Mesenchymal Transition Genes, Tumor Suppressor Time Factors Risk Gene Rearrangement, B-Lymphocyte Amino Acid Sequence Immunologic Memory Genes, Immunoglobulin Antibody Formation Radiation Tolerance Tumor Microenvironment DNA Damage Genes, p53 Gene Expression Regulation Transcriptional Activation Genes, Neoplasm Sensitivity and Specificity

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science5

Molecular Sequence Data Base Sequence Survival Rate Amino Acid Sequence Registries

Named Groups1

Health Care10

Survival Analysis Survival Rate National Cancer Institute (U.S.)Follow-Up Studies Retrospective Studies Risk Registries Prospective Studies Disease-Free Survival Sensitivity and Specificity

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

B-Lymphocytes Lymphoma, B-Cell Leukemia, B-Cell Leukemia, Lymphocytic, Chronic, B-Cell Cell Line, Tumor Gene Expression Regulation, Neoplastic Leukemia, Hairy Cell Apoptosis Cell Proliferation Tumor Cells, Cultured Waldenstrom Macroglobulinemia Cell Survival Neoplasms Neoplasm Invasiveness Burkitt Lymphoma Breast Neoplasms Antigens, CD19 Sialic Acid Binding Ig-like Lectin 2 Rhabdoid Tumor Prostatic Neoplasms Signal Transduction Antigens, CD20 Antibodies, Monoclonal Flow Cytometry B-Cell Activating Factor Mice, Nude Antibodies, Bispecific Neoplasm Metastasis Lymphoma, Non-Hodgkin Leukemia, Lymphoid Lymphoma Antineoplastic Agents Pancreatic Neoplasms Multiple Myeloma Antibodies, Monoclonal, Murine-Derived Receptors, Antigen, B-Cell Cell Movement Antigens, CD Mesothelioma Proto-Oncogene Proteins c-bcl-2 Lymphocyte Activation Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Antibody-Dependent Cell Cytotoxicity Cell Transformation, Neoplastic Antigens, Neoplasm RNA, Messenger Immunoglobulin Heavy Chains Immunoglobulin M Tumor Markers, Biological Lymphoma, Follicular Prognosis Colonic Neoplasms Neoplasm Proteins B-Lymphocyte Subsets Carcinoma, Squamous Cell Disease Progression Transcription Factors Cells, Cultured Ovarian Neoplasms Immunohistochemistry Lymphoma, Large B-Cell, Diffuse Lung Neoplasms Antibody Specificity Early Detection of Cancer Drug Resistance, Neoplasm RNA, Small Interfering B-Cell Activation Factor Receptor Stomach Neoplasms Blotting, Western Cell Division Antigens, CD5 Xenograft Model Antitumor Assays Down-Regulation T-Lymphocytes Drug Screening Assays, Antitumor Cell Cycle Cell Line Antigens, Differentiation, B-Lymphocyte Transfection Mice, Inbred BALB C Neoplasm Transplantation CD40 Ligand Up-Regulation Immunoglobulin Variable Region HCT116 Cells RNA Interference Transplantation, Heterologous MCF-7 Cells Cell Growth Processes HT29 Cells Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Promoter Regions, Genetic Phosphorylation Mutation Germinal Center Mice, Inbred C57BL Carcinoma Molecular Sequence Data

No FAQ available that match "aggressive cancer cells malignant b cells"